An Open-Label Treatment Protocol to Provide Continued Elvucitabine Treatment

NCT00675844 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Elvucitabine

Sponsor

Alexion Pharmaceuticals, Inc.

Collaborators

[object Object]